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Emil Behring’s Medical Culture:
From Disinfection to Serotherapy
JONATHAN SIMON*
Theintroductionofthefirstserumtherapiesforthetreatmentofdiphtheriaandtetanusin
the mid-1890s constitutes an important development in the history of medicine. The
technique—pioneered by Emil Behring (1854–1917)—involved the injection of blood-
serum extracted from animals after they had been rendered immune to the disease in
question. In retrospect, it is easy to identify this approach as providing the first effective
specific biological—as opposed to chemical—treatment for infectious diseases. Such a
retrospective assessment is, however, deceptive on several accounts; first, extracts of
animals—usually derived from blood, individual organs or specific glands—abounded
in this period and were used in all manner of indications both general and specific, from
extract of testicles for male impotence to extract of pancreas for problems of digestion or
diabetes. Thus, while it is easy to think of sera as distinct from these other ‘‘quack’’
medicines, because of their efficacy against specific diseases, this was far from clear
for doctors at the turn of the nineteenth and twentieth centuries. Second, it is quite natural
todaytothinkofthefunctionofsuchseraintermsofimmunologyandtheharnessingofthe
specificity of an animal’s immune response for curative or even preventive purposes, but
treatment using sera was introduced without any clear theoretical vision of how it might
work. To see how general the understanding of the serum’s action was at the time, we need
only recall Behring’s famous reflection on the purported value of blood transfusion that
concluded the first experimental success with this serum therapy: ‘‘Blood is a very special
juice’’.
1 Indeed, all the classic histories of bacteriology and immunology seek, quite
legitimately, to place Behring’s discovery within the early history of immunology.
2 In
this context, the development of serotherapy in Germany finds its principal role as an
assaultonMetchnikoff’sphagocytictheory,settingthestagefortheclashbetweenGerman
humoral and French cellular theories of immunity that is regarded as the discipline’s
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1Behring is here quoting Goethe’s Faust: ‘‘Blut ist
ein ganz besonderer Saft.’’ Emil Behring and
Shibasaburo Kitasato, ‘Ueber das Zustandekommen
der Diphtherie-Immunit€ at und der Tetanus-Immunit€ at
bei Thieren’, Deutsch. med. Wochenschr., 1890,
16 (49): pp. 1113–14, on p. 1113. Behring was at this
time well aware of the specificity of the anti-bacterial
activity of blood, as well as its apparent unpredic-
tability; Emil Behring, and F Nissen, ‘Ueber
bacterienfeindliche Eigenschaften verschiedener
Blutserumarten. Ein Beitrag zur Immunit€ atsfrage’,
Zeitschrift f€ ur Hygiene, 1890, 8: 412–33, on p. 431.
2WDFoster,Ahistoryofmedicalbacteriologyand
immunology, London, Heinemann, 1970, and more
recently, and with more contextual sensitivity, Arthur
M Silverstein, A history of immunology, San Diego,
Academic Press, 1989.
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3 Nevertheless, it was not the way in which Behring presented his work
that gave rise to serotherapy. Although he did reject the mechanism of phagocytosis,
Behring did not project his original research into the future of immunology, but chose
instead to present the blood serum in much more familiar terms, as an antiseptic or disin-
fectant. Why, we might ask, did he make any such reference to disinfection at all in this
context? Exploring this idea of disinfection, rather than simply inscribing serotherapy
into the early history of immunology, leads us to consider the broader meaning of dis-
infection in fin-de-si  ecle Germany as well as the use of disinfectants in micro-biological
research in Berlin at this time. This is the direction I follow in this paper by focusing on the
roleofdisinfection anddisinfectants inthe researchcareer ofEmilBehring.This trailleads
usfrom hisinitial publicationson iodoform—aninnovative, ifcontroversial disinfectant—
to the development of serotherapy over a decade later. Overall, the use of disinfection and
disinfectants as the organizing principle for presenting this historyobliges us to understand
the new therapeutic agent (animal-derived serum) less as the first therapeutic triumph of a
nascentfieldofimmunology,andmoreasapracticalachievementthatdependedonasetof
skills and reagents drawn from a variety of contexts, including, in particular, German
military medicine. Indeed, in this context it is much easier to understand why Behring so
readily interpreted his own elaboration of serotherapy, at least initially, in the disinfectant
tradition.
In this paper, therefore, I will start by considering the influence of military medicine and
Behring’s own medical career on his first publications on iodoform. Next, I want to show
howhisearlyinterest indisinfectantsled Behringlogically,ifnotinevitably,intothegroup
of microbiologists that had constituted itself around Robert Koch (1843–1910) in Berlin in
the 1880s.The final task istoshow howthe workthatled tothe introductionofserotherapy
was inscribed in the same tradition of disinfection research that had led Behring to Berlin
and his collaboration with Kitasato in the first place. Nevertheless, I end the study here,
withthefirstpublicationsontheprincipleofserotherapy.Althoughaninterestingstory,the
development and stabilization of the use of such serum in human medicine by Behring and
Erich Wernicke in the early 1890s is beyond the scope of this paper. Finally, while this is
essentially the story of a research career within the German empire, I refer to military and
industrialinfluencesthatinformedmedicaltheoryandresearchthroughoutwesternEurope
and the eastern United States. This is not intended, however, to be a comparative analysis,
and the alternative approaches that oriented research outside Germany are only briefly
alluded to in order to illustrate the specificity of the German configuration of microbio-
logical research and the prominent place assigned to disinfectants and disinfection in this
context.
The Origins of Serotherapy
The research that led up to the introduction of serotherapy as a treatment for diphtheria
and tetanus was shared between two centres for research in microbiology; the Pasteur
3Written fifty years after the events, Bulloch’s
historyisthefirsttomakeuseofthisdebatetomarkthe
transfer from bacteriology to immunology.
William Bulloch, The history of bacteriology,
London, Oxford University Press, 1938,
particularly ch. 11.
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Jonathan SimonInstitute in Paris and Koch’s group in Berlin. Indeed, the standard histories of the crucial
discoveries that form the mileposts on the way to the therapy take us regularly back and
forth from Prussia to France. While it was Friedrich Lo ¨ffler (1852–1915) who isolated the
bacillus associated with the disease in Berlin in 1882, and at the same time postulated a
mode of action involving the production of a toxin, it was E ´mile Roux (1853–1933) and
Alexandre Yersin (1863–1943) in Paris who, in 1888, first reported purifying the toxin
responsible for diphtheria’s peculiar gravity as a childhood disease.
4 We return to Berlin
forthe publicationin 1890by EmilBehringand ShibasaburoKitasato(1852–1931) ofaset
of experiments that introduced the possibility of rendering a rabbit immune to the toxin
associated with the tetanus bacilli by injecting it with blood serum taken from an animal
formerlyimmunized by other experimental means.
5Therace was then on tofindasafe and
practical way to convert this principle into a means for treating diphtheria in humans, an
application clearly predicted by Behring in 1890.
6 Nevertheless, the apparent continuity
behind this shuttling to and fro in the history disguises important differences in the
approaches adopted either side of the Vosges.
7 In part, this is a question of difference
in the national styles of microbiology. Koch’s development of sophisticated in vitro
techniques—including innovations in pure cultures—and a focus on specific animal-
disease models contrasts with the more empirical approach of Louis Pasteur (1822–95)
in which he favoured the passage of pathogens through animal hosts to try to accentuate or
later attenuate ‘‘viruses’’ for therapeutic applications. Furthermore, it can be argued that
Koch’s background as a doctor and his exclusive interest in medical microbiology meant
he was at once more focused on human infectious disease but lacked the breadth of
microbiological experience that came with Pasteur’s interest in the commercial,
particularly agricultural, relevance of micro-organisms.
8 Indeed, as far as paradigms
for developing effective treatments are concerned, Andrew Mendelsohn has argued
that the advent of serotherapy helped to undermine the centrality of projects for
producing vaccines by means of attenuation that characterized Pastorian medical science
until the death of its founder in 1895, and thus contributed to a closer alignment
between the French and German work in medical microbiology.
9 This, however, is not
the subject I want to treat here. The orientation I propose arises quite naturally if we
compare the recruitment at the Pasteur Institute with that at Koch’s Hygiene Institute in
4Emil Rouxand AlexandreYersin, ‘Contribution a `
l’e ´tude de la diphthe ´rie’, Annales de l’Institut Pasteur
1888, 2 (12): 629–61.
5Behring and Kitasato, op. cit., note 1 above.
6Ibid., and Emil Behring, ‘Untersuchungen € uber
das Zustandekommen der Diphtherie-Immunit€ at bei
Thieren’, Deutsch. med. Wochenschr., 1890, 16 (50):
1145–8.
7Starting in 1871, the Germans annexed Alsace,
whichwhilebeingagreatblowtoFrenchnationalpride
also constituted a significant motivation for the
scientific work of first Pasteur and later Roux.
8For a detailed and yet reflective intellectual
biography of Koch, see Christoph Gradmann,
KrankheitimLabor:RobertKochunddiemedizinische
Bakteriologie,G o ¨ttingen, Wallstein, 2005. There are
a number of biographies of Pasteur that analyse his
approach to microbiological research. The most
challenging is Gerald L Geison, The private science of
Louis Pasteur, Princeton University Press, 1995, but
other detailed presentations include Patrice Debre ´,
Louis Pasteur, Paris, Flammarion, 1994.
9Andrew Mendelsohn, Cultures of bacteriology:
formation and transformation of a science in France
and Germany, 1870–1914, PhD thesis, Princeton
University, 1996, pp. 299–309. Here, Mendelsohn
argues that Roux’s use of solid media, combined with
the skills brought to Paris from Germany by Yersin,
contributed to a re-alignment starting in 1885. Their
research on the virulence of germs progressively
adopted the use of antiseptics described in the present
paper. See pp. 313–35.
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10 It is striking that, while nearly all the researchers in Berlin were army medical
officers, few of the scientists at the Pasteur Institute had more than a distant connection to
the armed services. Indeed, Emile Roux’s dismissal from the French army, apparently for
insubordination, illustrates the distance that the first generation of Pastorians put between
themselves and the army.
11 Rather than take this to be simply a pragmatic result of Koch’s
recruitment policy—having the army pay for qualified staff was a way of keeping within a
limited budget—I want to explore how the military careers of these scientists might have
influencedtheir research interestsandapproaches,usingthe particularlysignificantcaseof
Emil Behring to illustrate my argument.
Behring and Iodoform
The first issue I will treat is, therefore, the place of military medicine in Behring’s
research. Here, I want to underline the importance of the chemical disinfectants that were
widely used in medicine during the second half of the nineteenth century, and became of
particular interest to the German army following the Franco-Prussian war. In brief, my
argument is that a set of experiments and publications concerning a number of such
disinfectants would provide Behring with the tools necessary for his work in Berlin
that touched on different therapeutic areas and eventually—almost accidentally—gave
rise to serotherapy. Indeed, we shall see that Behring’s early entry into the field of
disinfection was not only important for his career as a military doctor, but also influenced
his long-term scientific trajectory on two levels, providing two kinds of toolbox as it were.
First, the chemical disinfectants themselves supplied Behring with a collection of physical
research tools that he handled with skill in a widening range of applications. Second, the
theoretical background that conceived practically all medical treatment of infectious dis-
ease in terms of disinfection provided the means for thinking about his research into
possible cures for diphtheria and tetanus among other infectious diseases. Indeed, having
made his discovery of the curative power of the blood of an immune animal, Behring
consciously chose to consider the resulting serotherapy precisely in terms of this tradition
of disinfection. What was exceptional about this case, however, was that the disinfectant
was not a chemical agent, but the blood itself.
Thus, with respect to the therapeutic action of blood taken from other immunized animals, it is of
little importance whether it has a direct influence on the bacteria or disables the pathogenic power
of the bacteria’s metabolic product.
I believe that I have the right to call both of these alternatives disinfection of the living
organism.
12
In order to draw out the significance of this thread of disinfection-thinking in Behring’s
work, I will follow his research from his first publications on iodoform in 1882 to the
10Foracomparisonofthestructureandfunctioning
of Koch’s Institute for Hygiene and the Pasteur
Institute, see Paul Weindling, ‘Scientific elites and
laboratory organisation in fin de si  ecle Paris and
Berlin’, in Andrew Cunningham and Perry Williams
(eds), The laboratory revolution in medicine,
Cambridge University Press, 1992, pp. 170–88.
11For this story about Roux, see Mary Cressac, Le
Docteur Roux mon oncle, Paris, L’Arche, 1950. While
others, like Edmond Nocard, may have volunteered to
serve during the Franco-Prussian war, there were no
militarycareerdoctorsworkingforthePasteurInstitute
at this time.
12‘‘Eskommtdabeiwenigdaraufan,obwirbeiden
letztgenannten Heilwirkungen, die mit dem Blut
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Jonathan Simondevelopment of the serotherapy less than a decade later. While doing this, I also aim to
situate thechemicaldisinfectantsinvolvedintheindustrialandmilitarycontextofimperial
Germany in the second half of the nineteenth century.
The Early Publications of an Unknown Military Doctor
EmilBehring’scareerpathwasquitetypicalofthescientistswhostaffedKoch’sresearch
institute at the end of the nineteenth century. Like many other research-oriented doctors
whohadreceivedafreemedicaleducationcourtesyofthearmyandthenstruggledtoescape
fromtheunpredictablenatureofmilitarypostingsaroundPrussia,Behringfoundawayoutof
the constraints of a typical military career through his scientific medical publications.
Nevertheless, he knew that it was not by publishing case histories of diseases or their
standard treatments that he would attract the attention of his fellow ‘‘scientific’’ doctors.
Behring opened his publication career while posted at Posen,
13 an eastern outpost of the
Prussian empire, with a series of three articles on the organic chemical compound and
disinfectant, iodoform, all published in the Deutsche Medicinische Wochenschrift in
1882. The first, entitled ‘Ueber Jodoform und Jodoformwirkung’ (On Iodoform and its
Effects), concerned the chemical and physical characteristics of the compound, as well as
its reactions with a range of organic and inorganic reagents. The second article, ‘Ueber
Jodoformintoxication’ (On Iodoform Poisoning), was more clinical in its approach and
presented the various cases of poisoning associated with the use of this compound, while
the third, ‘Die Bedeutung des Jodoforms in der antiseptischen Wundbehandlung’
(The Significance of Iodoform inthe AntisepticDressing ofWounds), offered an overview
of the place and functioning of iodoform in the practice of disinfection.These three articles
reveal how Behring was seeking to situate himself as a chemistry-oriented medical
researcher while still a junior medical officer in the Prussian army, and I will have more to
say about them in what follows. From a professional perspective, however, while it would
be an overstatement to claim that these articles made his reputation, they nevertheless
attracted enough attention to start Behring on his way up and out of the standard career
as a military doctor to which he was otherwise destined. The authoritative tone of the third
paper in particular makes it clear that Behring was positioning himself as an arbiter in any
debate concerning the effectiveness or toxicity of this particular chemical disinfectant.
These three publications from 1882 did not, however, represent Behring’s first reflec-
tions on disinfectants. He had already put the elements of his own theory of disinfection
down on paper in the form of notes that date from the end of 1881.
14 Here, he summarized
three possible ways of avoiding putrefaction that reflect the three pre-conditions for the
occurrence of the phenomenon in the first place. First, one could try to make the nutritive
material that nourished the germs responsible for corruption unsuitable in some way.
Second, one could attempt to banish the germs responsible for the corruption, or third,
render these germs non-functional. Behring’s initial approach that underpinned his first
immunisirterandererThiereerzieltwerdenko ¨nnen,die
Bacterien direkt beeinflussen, oder ob wir die
krankmachenden Wirkungen ihrer Stoffwechsel-
producte paralysiren. Ich glaube ein Recht zu haben,
beides als eine Desinfection im lebenden Organismus
zubezeichnen.’’EmilBehring,‘UeberDesinfectionam
lebenden Organismus’, Deutsch. med. Wochenschr.,
1891, 17 (52): 1393–97, on p.1393.
13Today, Poznan in Poland.
14Behring Archive, Marburg; 08-04/T-II/ 1071,
from 22 December 1881.
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Emil Behring’s Medical Culturethree publications would focus on the first line of attack—making the nutritive material
unreceptive to putrefaction—famously taking smoked ham as his model of a medium
rendered resistant to germs by a physical intervention. It is important to note that this was
the only one of the three options that did not require dealing directly with the germs
responsible for the putrefaction, and so lent itself more obviously to a chemical line of
approach. Thus, while Behring was fully conscious of the role played by living micro-
organisms in the phenomenon of putrefaction, his approach to disinfection would not be in
the style of Joseph Lister’s anti-bacterial methods, where the immediate goal was to
eradicate the germs responsible for infection. What first attracted Behring’s attention
was instead the chemical action of disinfectants—particularly iodoform—on liquid or
solid bodily matter—the medium for infection—and not their purported bactericidal prop-
erties. With the benefit of hindsight, it is easy to make much of Behring’s emphasis on the
environment ofthe humanbody asa potentialallyinthe fightagainst infectious agents, but
I believe it is more important to concentrate on his interest in novel disinfectants. It was in
this context that he sought to distinguish himself as a young researcher by presenting an
intriguing (if not wholly convincing) interpretation of the action of one such disinfectant.
Indeed,itisinthisspiritthatBehringofferedhisfirstpublicationoniodoform.
15Here,as
I have already said, he described the chemical constitution and principal reactions of the
compound. The specific goal of this first article was to identify which reagents were
capable of releasing iodine from iodoform in a manner similar to heating the compound.
The use of classic reagents such as mineral acids and alkalis was, however, only a prelude
to the investigation that really mattered; the interaction between iodoform and the fluids
and solids found in living bodies. The use of the compound by surgeons depended on its
action at the sites of infection (composed of living matter, however damaged it may have
been) where its disinfectant properties were to be understood and verified. The assumption
underlying this approach was that iodoform was essentially an efficient means for deliver-
ing iodine to the site of infection. It was considered unnecessary to provide any further
empirical proof of iodoform’s efficacy, as the use of iodine as a disinfectant had already
been empirically well established. In the end, these rather unrevealing laboratory experi-
ments, which seemed to suggest that few such bodily products were capable of generating
iodine from iodoform, allowed Behring to formulate an ambitious novel hypothesis to
explain the peculiar virtue of iodoform in the treatment of wounds.
The inner working of the septic substances should be explained in the following way. Putrefaction,
like any other process of decomposition of a living thing, generates or makes available oxidizing
chemical bodies that generate iodine out of iodoform, as can be verified by microscopic
observation. This freshly generated iodine is demonstrably capable of rendering those substances
able to generate putrefaction [f€ aulnissf€ ahige Substanzen] incapable of doing so and thus stops
putrefaction in substances otherwise prone to it.
16
Thus, while iodine was the disinfectant material of reference, according to Behring,
iodoform generated a particularly powerful form of iodine that would stop putrefaction by
rendering the usually fertile terrain of traumatized living matter unsuitable. We can
15Emil Behring, ‘Ueber Jodoform und
Jodoformwirkung’, Deutsch. med. Wochenschr., 1882,
8 (11): 146–8.
16‘‘DieEinwirkungaufseptischeSubstanstenistin
folgender Weise zu erkl€ aren. Bei der F€ aulniss wie bei
allen lebhaften Zersetzungsprocessen enstehen oder
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Jonathan Simoninterpretthismodelastheoutcome ofhisdecisionayear previouslytopursue the‘‘smoked
ham’’ model of disinfection, as there is no obvious chemical reason for Behring to think
that any special form of iodine should be produced under these circumstances.
Behring’s second article represents a turn away from this chemical approach, as here he
addresses the clinical problem of poisoning associated with the compound.
17 In it, Behring
reports a collection of classic clinical cases of iodoform poisoning and the better-known
syndrome caused by its more widely used counterpart, iodine poisoning. He uses this
information as the basis for his opinion on the appropriate use of the compound, warning
his readers against the internal use of iodoform. The construction of this article around this
series of reports of clinical cases makes it a much more typical article for its time, as
Behring completely dispenses with the chemical analyses less familiar to most practising
doctors. Nevertheless, he comes back to chemistry in his conclusion, where he describes
the effect of iodoform on the nervous system as being similar to the effects of chloroform
poisoning. This is an opportunity to remind the reader of the similarity between the
chemical structures of these two organic compounds.
The final article in this initial series offers an overview of the current knowledge and use
of iodoform.
18 Behring takes a more authoritative tone than in the two preceding articles,
arguing that surgeons’ rejection of iodoform is not justified by iodine poisoning
(Jodismus), which is associated only with its internal use. Thus, while he re-affirms his
opinion that iodoform should not be used internally for the treatment of venereal disease or
cysts, he nevertheless defends the continued use of the chemical as an effective disin-
fectant. The tone of Behring’s conclusion that closed this hat trick of publications for 1882
suggests he was by now if not the expert, at the very least a figure who had to be taken into
account in any further discussion on the topic.
The Medical Uses of Iodoform
Why did Behring choose to publish on iodoform, and why did this substance merit such
detailed investigation? Addressing these two questions leads us to a consideration of the
special significance of disinfectants in imperial Germany, in particular in relation to
military medicine in the wake of unification and the Franco-Prussian war of 1870–71.
Behring’s orientation towards this substance was undoubtedly a career decision, as he
musthavebeenfullyawarethatiodoformwasacontroversialbutfashionabletopicforboth
clinical and physiological research, and the interest surrounding this relatively new dis-
infectant would facilitate hisfirst ventureinto print. Not onlywould it be easier toget these
first texts published, it would also be easier to get them noticed. As the Viennese surgeon,
Johannes Mikulicz (1850–1905) remarked at the beginning of 1882, ‘‘In the last few
months, the surgical literature has contained a whole range of useful articles on the use
sindvorhandenoxydirendechemischeKo ¨rper,die,wie
man sich durch mikroskopische Betrachtung
€ uberzeugen kann, aus Jodoform Jod entwickeln; das
Jod in statu nascendi ist aber nachweislich im Stande,
f€ aulnissf€ ahige Substanzen in f€ aulnissunf€ ahige zu
verwandeln und in faulenden Substanzen die F€ aulniss
zu sistiren.’’ Ibid., p. 147.
17Emil Behring, ‘Ueber Jodoformintoxication’,
Deutsch. med. Wochenschr., 1882, 8 (20): 278–9, and
8 (21): 297–298.
18Emil Behring, ‘Die Bedeutung des Jodoforms in
der antiseptischen Wundbehandlung’, Deutsch. med.
Wochenschr., 1882, 8 (23): 321–3, and 1882, 8 (24):
336–337.
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19Indeed,intheCentralblattf€ urChirurgieforthatyear,therewerethirty-four
entries concerning iodoform (including both original articles and reviews), compared with
only two on its more traditional counterpart, iodine. Why was there such an intense interest
in this compound? Iodoform was a product of chemical synthesis that started life in the
laboratory of a French pharmacist and chemist, Georges Se ´rullas (1774–1832), in 1822.
20
According to a review that appeared in Schmidt’s Jahrbuch for 1864, the compound was
subsequently introduced into medical practice by Dr Buchardat, based on the fact that it
contained 90 per cent iodine by weight.
21 As I have already suggested, the reasoning that
justified the clinical application of this new organic chemical was that it was essentially a
concentrated form of iodine, and would therefore possess disinfecting powers similar to, if
notbetterthan,thismorevenerableelementarydisinfectant.Thisinnovationindisinfection,
like many others at the time, was received enthusiastically in certain medical circles, and
doctors soon started experimenting with a wide range of external and internal applications.
For some time, iodine salts, such as potassium iodide, had been given internally for the
treatmentof syphilis, soit isunsurprising that the internal applications foriodoform should
focus on venereal disease. The most obvious use, however, was the external application to
disinfect superficial wounds, and in this context, iodoform was seen as simply a more
practical way of applying iodine. Interestingly, doctors also developed treatments that lay
somewhere between external disinfection and introduction into the bloodstream through
ingestion. Thus,in1880,forexample,WWatson Cheyne (1852–1932)publishedanarticle
on the use of a bougie made out of cocoa butter, eucalyptus oil and iodoform that was to be
inserted into the urethra as a treatment for blennorrhoea, recalling the longstanding func-
tion of iodides in the handling of venereal disease.
22 Beyond these direct medical uses,
however, the relative ease of manipulating iodoform permitted technical innovations in
disinfection. In 1873, for example, a Leipzig journal promoted the use of iodoform paper
instead of iodine for eliminating bad odours.
While the focus for internal use in German medicine was venereal disease, the applica-
tions suggested elsewhere were wide-ranging. In a review of Righini’s early treatise on
iodoformpublishedin1864,Kurzwellypresentsalonglistofdiseasesinwhich theproduct
could be usefully applied including tuberculosis, scrofula, menstrual problems, tumours,
retention of liquid in the uterus and breasts, male impotence, and more.
23 The same review
provided an equally wide range of modes for administering the medicine including the use
of ‘‘iodoform cigarettes’’ that mixed iodoform with belladonna for the treatment of tuber-
culosis, asthma, laryngitis and chronic pharyngitis by inhalation of the smoke.
24
Despite this range of applications, the principle interest for the military use of iodoform,
and the one that Behring ended up stressing in his early publications, was the art of
Wundbehandlung or the dressing of wounds, particularly gunshot wounds. Iodine had
established its place in this area early in the nineteenth century, and by the time Behring
19J Mikulicz, ‘Zur Jodoformbehandlung’,
Centralblatt f€ ur Chirurgie, 1882, p. 1.
20Iodoform—CHI3—is the homologue of
chloroform—CHCl3—with the chlorine replaced by
iodine.
21Kurzwelly, ‘Das Jodoform. Eine Monographie
mitR€ ucksichtaufChemie,Physiologie,Pharmacieund
Therapie, von Dr. J. Righini; aus dem Italienischen
€ ubertragen von Dr E. Janssens’, Schmidt’s Jahrb€ ucher
der in- und ausl€ andischen gesammten Medicin, 1864,
121: 25–31.
22W Watson Cheyne, ‘On a new method of
arresting gonorrhoea’, Br. med. J., 24 July 1880, ii:
124–5.
23Kurzwelly, op. cit., note 21 above, p. 29.
24Ibid., p. 31.
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Jonathan Simonstarted his research on iodoform, it was used widely as a disinfectant. Indeed, one of the
areas where this new chemical would find an enduring application was in iodoform
dressings that could be applied directly to open wounds or the site of amputations, and
could thus replace the standard combination of iodine and bandages. At the end of the
nineteenth century, with Lister’s technical innovation following on the microbial revolu-
tionofearlypioneerslikePasteur,theroleofdisinfectantsinmedicinewaschanging.Inthe
late 1860s, Lister himself quite clearly distinguished his approach of antisepsis from the
more traditional use of disinfectants in binding wounds:
In speaking of the antiseptic system of treatment, I refer to the systematic employment of some
antiseptic substance, so as entirely to prevent the occurrence of putrefaction in the part concerned,
as distinguished from the mere use of such an agent as a dressing. The latter has long been practised
in many parts of the world.
25
In the decade following the publication of his method, the reception of Lister’s approach
changed from scepticism to enthusiasm, and antiseptic techniques progressively won over
surgeons,who could thereby reduce the rate ofpost-operationalinfection and death in their
wards. From this perspective, alternative disinfectants like iodoform were of interest to a
surgical community increasingly in favour of Listerian antisepsis. Furthermore, in terms of
its physical characteristics—a water-insoluble solid at room temperature—this chemical
formed a bridge between the traditional dressing of wounds with iodine and Lister’s
phenol-based approach of antisepsis, although carbolic acid was used as a topical disin-
fectant as well.
Industry, Chemistry and Disinfection
If we look at the origins of Lister’s approach to antiseptis, we are inevitably confronted
with the significance of the industrial revolution and urbanization in the genesis of this
medicalrevolution.Thecarbolic(orphenolic)acidfavouredbyJosephLister (1827–1912)
for his antiseptic system, like other coal-tar derivatives, was a by-product of the production
of town gas that needed to be disposed of in one way or another. Thus, Lister recounts how
he was originally inspired by the use of this product in a sewage treatment project in
Carlisle.
In the course of the year 1864 I was much struck with an account of the remarkable effects
produced by carbolic acid upon the sewage of the town of Carlisle, the admixture of a very small
proportion not only preventing all odour from the lands irrigated with the refuse material, but, as it
was stated, destroying the entozoa which usually infest cattle fed upon such pastures.
26
Industrial logic naturally encouraged the use of this by-product of gas production for
other ends. Nor should the coincidence between such poisonous by-products of modern
urban technologies and the new microbial vision of disease and infection be passed over
without comment. The technological and practical innovations of nineteenth-century biol-
ogy that rendered bacterial agents visible under the microscope as well as allowing them to
25Joseph Lister, ‘An address on the antiseptic
system of treatment in surgery’, Br. med. J., 18 July
1868, ii: pp. 53–6, on p. 53.
26Joseph Lister, ‘On a new method of treating
compound fracture, abscesses, &c.’, Lancet, 16 March
1867, i: 326.
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Emil Behring’s Medical Culturebe collected, stored, and cultivated under laboratory conditions were of the same order as
those that drew unprecedented populations into towns seeking employment in factories.
The rise of analytic and synthetic organic chemistry was likewise increasingly integrated
into the process of industrialization, with interest in artificial dyes dependent on the mass-
manufacture of textiles in Britain and elsewhere. It was William Perkin’s (1838–1907)
discovery of mauve in 1856 that inaugurated the introduction of a range of phenol-based
dyes, a crucial area of industrial research and development that came to be dominated by
German chemical companies by the late nineteenth century. Thus, synthetic organic
chemistry not only freed the textile industry from its dependence on costly plant-based
dyes, but also supplied researchers with a host of new potential disinfectants to investi-
gate.
27 Although the synthesis of iodoform belonged to an earlier age of organic chemistry
than the artificial dyestuffs, its integration into medical use was contemporary. It is not,
therefore, surprising that a similar aura should surround iodoform as surrounded synthetic
dyestuffs, as they were both seen as modern products of the chemistry laboratory, and
symbolic of the science-based industrial power of a unified Germany. As is illustrated by
the concerns around iodoform poisoning, however, these chemicals were not regarded as
an unmitigated good.
28
War and Empire
Besidesitschemicalindustry,anothersymbolofthepowerofimperialGermany wasthe
defeatofFrance,itsformerimperialneighbourandtraditionalenemy,in1870.Theentryof
PrussiantroopsintoParis,andthecedingofAlsace-LorrainetoGermanywereexperienced
by the French as stinging humiliations, but at the same time were seen by the Germans as a
great victory of the newly unified nation. The Franco-Prussian war not only mobilized
large armies for modern warfare, but also brought with it a re-examination of many aspects
of military life, and military medicine was a prominent target for reform. Modern military
medicine was to be brought closer to the front to deal quickly with the large number of
wounds inflicted by increasingly effective artillery and more powerful small arms. The
response that had generalized since the Napoleonic wars over half a century earlier was the
mobile military hospital that could follow the army in its campaign and provide treatment
for soldiers relatively near the front line, soon after they had received their injuries. The
principal task of such a hospital was dressing the gunshot wounds of soldiers transported
from the front, and the indispensable tools for this task were bandages and iodine.
The potential importance of iodoform bandages for the Prussian military was evident, as
they constituted an effective means of combining disinfectant with bindings in a stable,
readily available form. The unification of Germany and the build-up of the imperial army
also encouraged the founding of new journals as well as other publications that specifically
addressed military medical issues. An example of this development is the Deutsche
Milit€ ar€ arztliche Zeitschrift
29 that first appeared in 1872, and, although dominated by
27Anthony S Travis, The rainbow makers: the
origins of the synthetic dyestuffs industry in western
Europe, Bethlehem, Lehigh University Press, 1993.
28For more on industrial chemical pollution
during this period, see the relevant contributions in
Ernst Homburg, Anthony S Travis, and
Harm G Schro ¨ter (eds), The chemical industry
in Europe, 1850–1914: industrial growth,
pollution and professionalization, Berlin,
Springer, 1998.
29The Deutsche Milit€ ar€ artzliche Zeitschrift was
published between 1872 and 1912. The early issues
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Jonathan Simonadministrative and regulatory announcements, contained a number of articles concerning
the use of disinfectants for cleansing wounds, as well as various antiseptic techniques and
materials for use in surgery and elsewhere. In 1875, for example, an article presented the
merits of carbolic and benzoic acids as disinfectants and preservatives for food, and 1877
saw the publication of investigations into the use of potassium chromate and hydrogen
chlorideaswellascoaltar—theresiduefromburningcoaltoproducegas—asdisinfectants
for use in dressing wounds. Thus, Behring’s publications in 1882 formed part of this wave
of interest in the military applications of new chemical disinfectants, in tune with the idea
that the application of modern chemicals could improve the emergency treatment of
gunshot wounds in particular. Beyond providing a receptive audience for investigations
into new disinfectants suited to modern military medicine, however, the German army also
played a crucial administrative role in Behring’s scientific career following his initial
publications on iodoform.
Carl Binz, Disinfectants, and Cadaverine
In 1883, Behring left Posen to take up a position at Winzig,
30 where, in 1884, he
published an article on the subject of iodoform poisoning.
31 Two years later, he was
transferred to Bojanowo; a smaller town, although somewhat closer to his earlier posting
in Posen.
32 During April and May of 1886, however, Behring was given leave to take a
bacteriology course with August Falk in Wiesbaden on the other side of Prussia, near the
Rhine.
33 The following year, Behring would receive an official appointment in the Rhine
valley, with a change in affiliation taking him to the Institute for Pharmacology in Bonn. It
isquitelogicalthathisseriesofpublicationsoniodoformfrom1882shouldleadBehringto
Carl Binz (1832–1913), the director of the Institute for Pharmacology. A senior military
doctor, and specialist in the physiological and chemical investigation of disinfectants, few
were better placed than Binz to oversee the continuing experimental education of Behring
inthisfield. Thus,in 1887, once he had qualified asa ‘‘Stabsarzt’’,Behring was transferred
from Bojanowo to the Institute at Bonn. This move, like his subsequent departure from
Bonn to join Koch’s research group in Berlin in 1889, was a military administrative
decision, but one certainly aimed at giving institutional recognition for Behring’s early
publications on iodoform and providing him with the possibility of building up this area of
expertise.ThistransferalsodefinitivelytookBehringoutofapotentiallyunendingcycleof
provincial postings in eastern Prussia, marking his promotion to a new level of research
activity.
34
Indeed,BinzwasoneofanumberofGermanmedicalresearcherswhowereinterestedin
examining the growing range of disinfectants generated by German industrial organic
were edited by Dr Leuthold, Oberstabarzt at the
Invalidenhause in Berlin.
30AlthoughinSilesia,Winzig—nowpartofPoland
and known as Wi  nsko—was a few hundred kilometres
south of Posen.
31Emil Behring, ‘Ueber Jodoformvergiftung und
ihre Behandlung’, Deutsch. med. Wochenschr., 1884,
10 (5): 68–70.
32A small town about 50 miles south of Posen,
Bojanowo is today in Poland.
33H Zeiss and R Bieling, Behring: Gestalt und
Werk, Berlin, B Schultz, 1940, p. 39.
34The loss of the relevant Prussian military
documents makes it impossible to confirm this
hypothesis concerning the aims of the military
command in this case.
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Emil Behring’s Medical Culturechemistry, and the scientists under him at the Institute for Pharmacology in Bonn were
deploying an improving arsenal of analytic organic and pharmacological techniques to
understand the nature and action of these chemicals. In his own publication on iodoform
from 1878, Binz noted that while much was known about the use of the compound as a
superficial disinfectant, relatively little experimentation had been performed to elucidate
its internal action. As he pithily summed up the situation ‘‘little certain is known about the
inner working of iodoform’’.
35 Although others at Bonn had studied certain aspects of
iodoform, Behring’s work represented the most thorough and original contribution to
knowledge about this particularly promising modern disinfectant, and so his transfer to
Bonn must have appeared quite natural.
36
Upon Behring’s arrival at the Institute for Pharmacology, Binz encouraged him to orient
his studies more toward bacteriology, following up the initiative of the course he had taken
in 1886. The move to Bonn had another dimension that is particularly relevant for the
present argument, as it signalled Behring’s immersion in a wider world of disinfectants
than he had hitherto known. From a notebook that he started in Bonn in 1887, it seems that
it was only here that Behring applied himself to gaining a thorough knowledge of organic
chemistry.
37 After this course in chemistry, he continued to make notes on recent work in
synthetic organic chemistry, paying particular attention to the new synthetic colorants
being produced by German industrial scientists. As I have already suggested, these color-
ants were not only of interest to microbiologists for dyeing their specimens, but also
provided a source of potential new disinfectants. Behring’s continued interest in disin-
fectants coupled with a growingexpertisein bacteriology is confirmed by hiscontributions
to scientific journals while in Bonn. In 1887, he published an article on the action of silver
solution on the anthrax bacterium,
38 and the following year, articles on the disinfectant and
antiseptic properties of mercury chloride, an acetic acid complex formed with mercury
chloride (Weins€ auresublimat), and creolin (another phenolic coal-tar product). These
papers do not pursue the ‘‘smoked ham’’ model of disinfection applied to the action of
iodoform, but are more ‘‘classic’’ analyses of these disinfectants in terms of their bacter-
icidal properties. Two other papers appeared in the Deutsche Medicinische Wochenschrift
of 1888, however, that took Behring back to reconsider his theory of the anti-putrefying
action of iodoform. First,in June,he publisheda paper on the possiblerole ofcadaverine in
the symptomology of cholera. Following up other research that showed that this organic
compound
39 was generated by certain bacteria, Behring’s first goal was to prove that
cadaverine was itself toxic. He did this by means of experiments on a variety of animals,
particularly guinea-pigs. He then argued by analogy from the associated symptoms and
post-mortem observations that cadaverine could be responsible for at least some of the
35‘‘Wenig Sicheres ist von der innern Wirkung des
Jodoform bekannt.’’ Carl Binz, ‘Ueber Jodoform und
€ uber Jods€ aure’, Archiv f€ ur experimentelle Pathologie
und Pharmakologie, 1878, 8: 309.
36In1877,CarlMo ¨llerdefendedadissertationatthe
Rheinischen Friedrich-Wilhelms-Universit€ at in Bonn,
half of which was dedicated to iodoform. Carl Mo ¨ller,
Pharmakologische Untersuchungen € uber Jodoform
und Jods€ aure, MD thesis, Rheinischen Friedrich-
Wilhelms-Universit€ at, 1877.
37Behring Archive, Marburg, 08-04/T-II/1083.
38Emil Behring, ‘Der antiseptische Wert der
Silberlo ¨sungen und Behandlung von Milzbrand mit
Silberlo ¨sungen’, Deutsch. med. Wochenschr., 1887, 13
(37, 38): 805–7, 830–4.
39Pentamethylendiamine, or 1,5-diaminopentane
had become increasingly identified with the chemical
principle thought to be responsible for the putrefaction
of dead bodies, cadaverine.
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Jonathan Simonsymptomsassociatedwithcholera. Thisinterest incadaverineand itstoxiceffectsreceived
anewtwisttwomonthslaterwhenBehringpublishedanarticleontherelationshipbetween
this compound and iodoform. Here, he elucidated a chemical mechanism by which iodo-
form could neutralize the cadaverine that he had already identified as a poisonous product
of certain pathogenic bacteria. He proposed that the three iodine atoms of each iodoform
molecule (CHI3) would be replaced by three cadaverine molecules (CH(cadaverine)3)t o
give a harmless product. This evidently shows a shift in Behring’s thinking away from his
originalmodelofthedisinfectivepowerofiodineinwhichheby-passedtheroleofbacteria
by postulating that the iodoform rendered organic matter unfit for the micro-organisms
responsible for putrefaction. In this new model, the bacteria are rendered harmless by
neutralizing their toxic products; a vision that justifies Behring’s conclusion that iodoform
should qualify neither as an antiseptic nor as a disinfectant in the currently accepted sense
of the terms—that they kill bacteria—because this was not its mechanism of action. Thus,
despite a new, clearly signalled orientation towards microbiology, Behring retained his
own particular understanding of iodoform as a ‘‘disinfectant’’, continuing to conceive it as
a neutralizing chemical reagent rather than as a bactericide. Furthermore, the time spent in
Bonn seems to have given Behring the chemical knowledge to propose a more plausible
mechanism (in chemical terms at least) for this action.
The article on cadaverine and iodoform not only reveals this shift in Behring’s thinking
about the chemical action of iodoform, it also brings to light his widening circle of both
scientific and institutional collaborators. Thus, Behring introduces the reader to a network
of researchers grouped around both the supply of cadaverine and ongoing physiological
experimentation. The first, Ernst von Scheurlen (1863–1897), was Behring’s long-time
friend and collaborator, but there were others such as de Ruyter and Julius Petri (1852–
1921) in Berlin, and Albert Ladenburg (1842–1911) in Bonn. Furthermore, a need for raw
materialsforthisresearchbroughtBehringintocontactwithEmanuelMerck(1855–1923),
a prominent member of the successful entrepreneurial Merck family, whose wholesale
laboratory in Darmstadt was able to supply pure cadaverine. Behring also had contact with
students working on disinfectants in Bonn. In April 1889, for example, Oscar Kniffler
defended his dissertation on ‘The Inner Application of Iodoform’ at the Medical faculty, in
which he cited a number of experiments that Behring was carrying out at the time. At the
end, Kniffler of course thanked Binz as director of the project, but he also explicitly
acknowledged Behring for ‘‘his friendly support’’ and his willingness to discuss the
student’s work.
40 Nevertheless, despite the significance and relevance of the research
being carried out at Bonn, the focus for scientific ambition under the German empire
remained at its capital city, Berlin.
41
Koch’s Institute, Serum, and other Disinfectants
The move to Koch’s Hygiene Institute in Berlin coincided with the highpoint of Behr-
ing’s scientific research, as it was in Berlin that he would make the breakthroughs leading
to serum therapy first for diphtheria, and later for tetanus. This discovery brought him
40Oscar Kniffler, Jodoform zur inneren
Anwendung, MD thesis, Rheinische Friedrich-
Wilhelms-Universit€ at, 1889, p. 33.
41Behring was transferred to Robert Koch’s
Institute in Berlin in July 1889.
213
Emil Behring’s Medical Cultureinternational recognition in the form of a Nobel Prize, the enduring status of a hero in
German history of medicine, as well as his own successful business producing serum. It
was also as a researcher at the Hygiene Institute in Berlin that Behring would present
himself as the new expert on disinfectants, and a potential successor to Koch. Thus, in
1890, the same year in which he made public the fruits of his collaborative research with
Kitasato on the curative powers of serum, Behring also published a review of disinfectants
under his own name.
42 Unlike the research on serum, this latter article appeared in Koch’s
journal,theZeitschriftf€ urHygiene,and,overthecourseofeightypages,Behringdiscussed
a wide range of disinfectants with which he was now familiar, and which would play a
crucial role in the practical development of serum therapy.
43 The disinfectants were
divided into eight sections, with the first six defined according to the physico-chemical
nature of the agents: metal salts, acids and alkalis, organic compounds based on the
aromaticring(phenols),liquiddisinfectantsinsolubleorslightlysolubleinwater,insoluble
solidsubstances, andgaseous substances.Thus, iodoform falls into the fifth categoryof the
insoluble solid disinfectants, where it is joined principally by preparations derived from
mercury,goldandotherheavy metals. Behringmaintainshiseccentric positionthat,unlike
the other chemicals he discusses, iodoform is not a bactericide but instead works by acting
on the environment to undermine the bacteria’s capacity to survive. The reaction between
cadaverine and iodoform published two years earlier does not, however, make it into this
review of disinfectants.
I do not intend to go through all the chemical disinfectants that Behring discussed under
these six headings cited above, but will consider only iodine trichloride, a double halogen
compound that would supply the initial technical means adopted by Behring and Erich
Wernicke (1859–1928) to immunize large animals (initially sheep, and ultimately horses)
against diphtheria. Thus, it was the use of this particular disinfectant that provided the key
to the initial production of serum for the treatment of diphtheria. My selective treatment of
iodine trichloride is, however, to save space rather than for any more principled reason.
Indeed,thepointIwanttounderline hereisthattheuseofthisagentfollowedaprogramme
of research that screened a wide variety of chemicals in the context of investigations that
also experimented with a range of therapeutic strategies. Thus, the identification of the
technique using iodine trichloride and the subsequent development of serum therapy was
an empirical outcome of this wide-ranging approach rather than being a deliberately
planned use of the chemical based on any theoretical principles.
For Behring, iodine trichloride is a more typical disinfectant than iodoform, as it has
direct anti-bacterial properties that are observable in vitro, using colonies of pathogenic
micro-organisms cultured on a suitable medium. Following a series of tests that compared
carbolic acid, mercurysublimate (chloride) andiodinetrichloride in terms oftheir capacity
to kill anthrax bacilli, and their toxicity in rabbits, iodine trichloride was singled out as
having the most favourable ratio of disinfectant power to toxicity. Behring also took the
opportunity of this article to announce the therapeutic success he had obtained by injecting
42It is interesting to note that in January 1890,
Behring was taking a course in hygiene at the Robert
KochInstitute,inwhichOscarBoertaughta sectionon
theactionofdisinfectantsonbacteria,08-04/T-II/1086,
‘Bericht € uber einen Kursus im Institut von Robert
Koch’.
43Emil Behring, ‘Ueber Desinfection,
Desinfectionsmittel und Desinfections-
methoden’, Zeitschrift f€ ur Hygiene, 1890, 9: 395–478.
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Jonathan Simoniodine trichloride into the site of an earlier injection of a virulent diphtheria culture. The
fact that the disinfectant was being used to eliminate the pathogen inside the animal’s body
is significant, but not extraordinary, and certainly cannot be straightforwardly read as a
conceptual precursor for Behring’s serotherapy. This kind of ‘‘inner disinfection’’ tech-
nique, involving the internal administration of disinfectants to cure microbial infections,
had also been used, for example, by Georg Cornet in the context of the search for a
treatment for tuberculosis. Nevertheless, it is important to remember that this type of
inner disinfection technique was just one out of many used by German researchers in
the 1880s in an effort to develop therapeutic applications in the realm of medical micro-
biology, as will be discussed in more detail below. Furthermore, while Behring judged
iodine trichloride to be the most effective agent in this context, it was not the only
disinfectant to impress him during the course of these studies.
Iodine trichloride is not the only compound with which one can obtain good therapeutic results on
guinea-pigs with diphtheria. Others such as naphthylamine, and gold-sodium chloride among the
metal salts, have proved effective. Nevertheless, up until now the best results have been achieved
using iodine trichloride.
44
Followinghispresentationofalargenumberofwell-defined,relativelypureorganicand
inorganic chemicals, Behring introduced a new form of disinfectant that was of quite a
different nature. Indeed, the last two types of disinfectant listed in Behring’s review from
1890 were not defined in chemical terms at all but instead according to their origin and
action; these were, first, chemical products from micro-organisms, and second, bacter-
icides present in animals and humans, i.e. their blood. While he has little to say about the
first of these, he stresses the radical novelty of the second. Thus, he not only characterizes
blood sera as ‘‘disinfectants’’ but also claims that this discovery constitutes a new ‘‘chapter
in disinfection theory’’. To understand this connection between serotherapy and disinfec-
tion, we need to look at the context of microbiological research in Berlin at this time,
opening our perspective to include a group of experimental scientists who, like Behring
himself, had gravitated towards Koch in Berlin.
Berlin, Disinfection and Serotherapy
The discovery by Kitasato and Behring that the blood of immune animals could be used
as a treatment for experimental tetanus and diphtheria (in other animals) led to the search
for reliable means to induce immunity in animals, with the aim of producing a serum that
could eventually be used in human disease. It is only too easy to trace out this path from
animal experiments to the human application of serotherapy once one is armed with the
knowledge that this technique was destined to become an important element of the modern
therapeutic arsenal. Nevertheless, in examining the research itself, we need to bear at least
two things in mind. First, it was far from certain that this approach would succeed for a
number of reasons. Not only was there a possibility that no operational means could be
44‘‘Das Jodtrichlorid ist nicht das einzige Mittel,
mit welchem manguteHeilresultatebei derDiphtherie
der Meerschweinchen erzielen kann ; auch
Naphthylamin und unter den Metallsalzen namentlich
das Goldnatriumchlorid erwiesen sich wirksam;
indessen waren bis jetzt die Erfolge mit dem
Jodtrichlorid die besten.’’ Ibid., p. 464.
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Emil Behring’s Medical Culturefound to immunize animals, but it was also far from certain that a treatment that worked in
rabbits would be effective for human beings. Second, this line of research was just one
among many undertaken in the effort to find an effective treatment for infectious diseases
such as diphtheria, tuberculosis and tetanus, following the relatively recent identification
of a series of micro-organisms as responsible for the pathologies in question. Thus, both
Kitasato and Behring’s initial investigations and the subsequent experiments aimed at
inducing immunity were conducted in the context of a considerable amount of related
animal experimentation aimed at developing therapies for infectious diseases. While
relatively few of these projects would result in applied, let alone effective therapies,
the researchers were evidently not in a position to know this at the time. Furthermore,
this microbiological research directed towards therapeutic applications itself took place in
a context of vigorous competition both within and outside the Berlin research community.
Even before the apparent success of Pasteur’s treatment for rabies in the mid-1880s, the
racewasontodevelopasuccessfultherapyforamajordiseasesuchasdiphtheriaortetanus
(or the greatest prize of them all—tuberculosis), with the Pasteur Institute a powerful
competitor of Berlin’s Hygiene Institute.
45 Nor was Behring alone in conducting this kind
of research in Berlin, with Georg Cornet (1858–1915), Carl Fraenkel (1861–1915), Hans
Aronson (1865–1919), Oscar Boer (1847–1897) and Robert Koch himself all engaged in
animal experimentation that was meant to result more or less directly in therapeutic
applications. In what can best be described as a loosely-integrated, wide-ranging research
programme, these German medical scientists deployed a variety of techniques, running the
gamut from the most ‘‘traditional’’ approach of attenuating the bacteria using heat or
chemicals—pioneered by Pasteur—to the pre-treatment of experimental animals with
disinfectants such as hydrogen peroxide, before infecting them with a pathogenic bacillus.
On the one hand, some of these approaches—such as feeding animals with the toxin
produced by a bacterium, to accustom their bodies to its effects—were far removed
from any disinfection techniques. On the other, as I mentioned above, various forms of
‘‘inner disinfection’’ were considered promising approaches, with Behring and others
attempting to cure infected animals by the internal administration of disinfectants both
before and after infection.
46 The concept of inner disinfection, however, itself covered
quite a broad range of practices, accompanied by similarly diverse interpretations of its
possible mode of action. Thus, in his 1889 article on the internal action of disinfectants on
animals infected with tuberculosis, Cornet hypothesized that the ‘‘bathing’’ of the infected
45This competition around the diphtheria antitoxin
is well analysed in Paul Weindling, ‘From medical
research to clinical practice: serum therapy for
diphtheria in the 1890s’, in John Pickstone (ed.),
Medical innovations in historical perspective, New
York, St Martin’s Press, 1992, pp. 72–83. For more on
the history of tuberculin as a treatment, see Christoph
Gradmann, ‘Redemption, danger and risk: the
history of anti-bacterial chemotherapy and the
transformation of tuberculin’, in Thomas Schlich
andUlrichTro ¨hler(eds),Therisksofmedicalinnovation:
risk perception and assessment in historical context,
London, Routledge, 2005, pp. 53–70.
46The nine methods retained by Behring in his
subsequent account of the period were the following:
sterilizing the bacteria at high temperature, pretreating
the culture with iodine trichloride, using the bodily
fluids of sick animals to induce immunity in others,
using chemical agents to cure infected animals, using
hydrogen peroxide (a disinfectant) as a prophylactic,
employing attenuated bacteria culture followed by a
full strength one, using pre-treated toxin, trying
incremental doses of toxin, and feeding the animals
with the toxin. See Emil Behring, Die Geschichte der
Diphtherie. Mit besondere Ber€ ucksichtigung der
Immunit€ atslehre,Leipzig,GeorgThieme,1893,p.148.
216
Jonathan Simonfleshindisinfectantcouldsterilizeitandsostopthespreadofthebacteria.
47Bycontrast,as
we have already seen, Behring qualified the ability of blood to neutralize the toxins
produced by bacteria in the same terms of disinfection.
It was in the context of this therapeutic disinfection research programme that Behring
conducted a series of experiments in collaboration with Boer, involving the use of some
thirty chemical agents to try and cure animals already infected with ‘‘experimental’’
diphtheria,
48 which was a continuation of Behring’s own longstanding attempts to treat
anthrax in laboratory animals by the same means. In parallel to the continued pursuit of
traditional disinfectants, Behring was also studying the disinfective power of blood. This
research started with experiments on the bactericidal effects of rats’ blood on anthrax
bacilli while Behring was still in Bonn, but was pushed much further in collaboration with
Franz Nissen, when Behring arrived in Berlin. Not all blood was the same in terms of its
bactericidal effects, and, in particular, while blood from normal guinea-pigs had no effect
against the Vibrio metschnikovi, blood from animals immunized against this bacterium
could kill it in vitro. Although this result led Behring to recognize the specificity (and
unpredictability!) of blood’s antibacterial properties, and even prompted him to speculate
about the possibly non-chemical origin of these properties, this work is still much closer to
the disinfectant tradition than any alternative explanation of immunity, as he continued to
think of blood as containing a collection of disinfectants.
Finally,Behring’s workwith Kitasatoonthetransferofimmunityagainstdiphtheriaand
tetanus using the animals’ blood-serum followed on directly from this research on the
antiseptic power of blood serum, with the serum’s action conceptualized as a form of inner
disinfection. The idea was that the specific bactericidal power of serum from immunized
animals that had been observed in vitro acting against the Vibrio metschnikovi, was being
applied internally.
The success of Behring and Kitasato’s transfer of immunity, and the therapeutic vistas it
opened up, lent Behring’s more traditional range of disinfectants a different practical
significance. If the injection of hydrogen peroxide, for example, could, by means of
some form of internal disinfection, protect an animal against the lethal effects of diphtheria
and thereby help to render it immune, then the techniquecouldpotentiallyserveto produce
serum for treating other animals or even humans suffering from the disease. Thus, rather
than taking the risk of injecting diphtheria patients with hydrogen peroxide directly, there
nowexistedtheapparentlysaferpossibilityofusingthesameprocedureinanimalsinorder
togenerate aserumforhuman administration. Inthe end, Behring’sfavoured techniquefor
inducing immunity—the essential preliminary for extracting the therapeutic serum—was
not any form of inner disinfection, however, but the pre-treatment of a diphtheria culture
(and later the toxin) using iodine trichloride. This manipulation rendered the culture or
toxin lessdeadly and thereby facilitated the process ofimmunization. Following this initial
47Georg Cornet, ‘Ueber das Verhalten der
TuberkelbacillenimthierischenOrganismusunterdem
Einfluss entwickelungshemmender Stoffe’, Zeitschrift
f€ ur Hygiene, 1889, 5: 100–1, cited in Gradmann, op.
cit., note 8 above, p. 138.
48Oscar Boer, ‘Ueber die Behandlung
diphtherieinfizierter Meerschweinchen mit
chemischen Pr€ aparaten’, Zeitschrift f€ ur Hygiene
und Infektionskrankheiten, 1892, 11: 154–64.
‘‘Experimental’’ disease was the term used to
describe human disease induced in an
animal usually by the inoculation of a bacterial
culture.
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Emil Behring’s Medical Culturestage, Behring successively reduced the iodine trichloride concentration in subsequent
injections oftoxin, until the animal couldeventually be exposed to untreated toxin, thereby
completing the process of artificial immunization. This initial successful method devel-
oped for immunizing large animals was put in place following a painstaking trial and error
investigation conducted by Wernicke in collaboration with Behring.
49 The addition of
iodine trichloride prior to injecting the culture was not a novel technique developed
specifically in this context, however, but one of the range of disinfection techniques
that were being explored by Boer and by Fraenkel as well as by Behring himself in
the therapeutic disinfection research programme outlined above. Here, then in the initial
elaboration of serotherapy for human use, we witness the practical utility of certain
experimental disinfection techniques. These resulted from the experimental extension
(to therapeutic applications in infectious disease) of the investigation of new potential
disinfectants that were of capital importance to a (military) medical culture increasingly
sensitive to issues of disinfection. In this light, it is no longer surprising that Behring
conceived this new therapy in terms of disinfection, as this was the context out of which it
arose. It is only after serotherapy has been located in the history of immunology, however,
and the history of experimental therapeutic disinfection techniques has disappeared from
sight, that Behring’s research career loses its coherence and his interpretation of serother-
apy as disinfection starts to sound so eccentric.
Conclusion
Behring’s initial interest in iodoform seems to have been motivated as much by profes-
sional as by scientific concerns, and yet it introduced him into a world of disinfectants that
would exercise a crucial influence over his subsequent medical research. This interest in
disinfectants, although military in origin, was widely shared in the circle of Berlin scien-
tists working on infectious disease at Koch’s Institutes, including Koch himself. Thus,
disinfectantsplayedatripleroleinBehring’sresearchcareer,first,anintroductoryroleasa
therapeutic agent in military medicine that led him from ‘‘mundane’’ concerns of dressing
wounds into an innovative area of therapeutic microbial research being conducted in
Berlin. Second, disinfectants played an important material role in his research, as the
wide range of substances (in particular organic chemicals synthesized in the context of the
new dye industry) served as a rich resource for solving biological problems, such as how to
develop a practical technique for immunizing different animals against microbial infec-
tious disease. Last, but not least, at the theoretical level, the action of disinfectants—
disinfection or antisepsis—provided a model for thinking about many different types of
therapy. Despite the fact that the conception of serotherapy as disinfection would rapidly
become outmoded in the wake of more coherent and convincing theories of immunity, it
was a key factor in developing this new therapy. Thus, I want to argue, the medical
revolution of serotherapy owed much more to the wide-ranging programme of practical
microbiological experimentation, which to a large extent turned around modern chemical
disinfectants, than to any particular immunological theory.
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